Relapsing vivax malaria after 6 months of daily atovaquone/proguanil in Afghanistan: The case for expanded use of primaquine as a causal prophylactic

Journal of Travel Medicine

Volumn 14, Issue 6, 2007, Pages 411-414

  Maguire, Jason D ^a,b   Llewellyn, David M ^a  

^a US Military Hospital   (Kuwait)

^b NAVAL MEDICAL CENTER PORTSMOUTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATOVAQUONE PLUS PROGUANIL; PRIMAQUINE;

ADULT; AFGHANISTAN; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CASE REPORT; CHEMOPROPHYLAXIS; CLINICAL FEATURE; DRUG WITHDRAWAL; ENDEMIC DISEASE; HUMAN; INFECTION PREVENTION; MALARIA; MALARIA CONTROL; MALE; PLASMODIUM VIVAX; RECURRENT INFECTION; SOLDIER;

ADULT; AFGHANISTAN; ANTIMALARIALS; ATOVAQUONE; CHLOROGUANIDE; DRUG THERAPY, COMBINATION; HUMANS; MALARIA, VIVAX; MALE; MEFLOQUINE; MILITARY PERSONNEL; PATIENT COMPLIANCE; PRIMAQUINE; RECURRENCE; TRAVEL;

EID: 35948976872     PISSN: 11951982     EISSN: 17088305     Source Type: Journal    
DOI: 10.1111/j.1708-8305.2007.00153.x     Document Type: Article

References (17)

1. Centers for Disease Control and Prevention. Health Information for International Travel 2005-2006. Atlanta, GA : U.S. Department of Health and Human Services, Public Health Service, 2005.
2. Shanks GD, Edstein MD. Modern malaria chemoprophylaxis. Drugs 2005 65 : 2091 2110.
3. Murray L, ed. Physicians' desk reference. 59th Ed. Montvale, NJ : Thompson PDR, 2005.
4. Berman JD, Nielsen R, Chulay JD, et al. Causal prophylactic efficacy of atovaquone-proguanil (Malarone) in a human challenge model. Trans R Soc Trop Med Hyg 2001 95 : 429 432.
5. Baird JK, Fryauff DJ, Hoffman SL. Primaquine for prevention of malaria in travelers. Clin Infect Dis 2003 37 : 659 667.
6. Fryauff DJ, Baird JK, Basri H, et al. Randomized placebo-controlled trial of primaquine for prophylaxis and vivax malaria. Lancet 1995 346 : 1190 1193.
7. Soto J, Toledo J, Rodriquez M, et al. Primaquine prophylaxis against malaria in nonimmune Columbian soldiers: efficacy and toxicity. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1998 129 : 241 244.
8. Soto J, Toledo J, Rodriquez M, et al. Double-blind, randomized, placebo-controlled assessment of chloroquine/primaquine prophylaxis for malaria in nonimmune Columbian soldiers. Clin Infect Dis 1999 29 : 199 201.
9. Baird JK, Lacy MD, Basri H, et al. Randomized, parallel placebo-controlled trial of primaquine for malaria prophylaxis in Papua, Indonesia. Clin Infect Dis 2001 33 : 1990 1997.
10. Sanofi-Aventis. Primaquine phosphate tablets, USP prescribing information. Available at : http://products.sanofi-aventis.us/primaquine/ primaquine.html. (Accessed 2006 Sep 26)
11. Assha AW. Afghanistan country report. Inter-country meeting of national malaria program managers Muscat, Oman; 2002 Mar 24-28 Kabul, Afghanistan : Institute of Malaria and Parasitic Diseases, 2002.
12. Assha AW. Rolling back malaria in Afghanistan country report. Fourth inter-country meeting of national malaria program managers Isfahan, Islamic Republic of Iran; 2004 May 25-28 Kabul, Afghanistan : Institute of Malaria and Parasitic Diseases, 2004.
13. Rab MA, Freeman TW, Rahim S, et al. High altitude epidemic malaria in Bamian province, central Afghanistan. La Revue de Sante de la Mediterranee orientale 2003 9 : 232 239.
14. Kotwal RS, Wenzel RB, Sterling RA, et al. An outbreak of malaria in US Army Rangers returning from Afghanistan. JAMA 2005 293 : 212 216.
15. Povinelli L, Monson TA, Fox BC, et al. Plasmodium vivax malaria in spite of atovaquone/proguanil (malarone) prophylaxis. J Travel Med 2003 10 : 353 355.
16. Hill DR, Baird JK, Parise ME, et al. Primaquine: report from CDC expert meeting on malaria chemoprophylaxis I. Am J Trop Med Hyg 2006 75 : 402 415.
17. Bryan JP. Cost consideration of malaria chemoprophylaxis including use of primaquine for primary or terminal chemoprophylaxis. Am J Trop Med Hyg 2006 75 : 416 420.